Accrol Group appoints Euan Hamilton to its Board as Independent Director

– UK, Blackburn – Accrol Group Holdings plc (AIM:ACRL), the leading independent tissue converter, today announced that Euan Hamilton has been appointed Independent Non-Executive Director with immediate effect. Euan replaces Stephen Hammett, who has today stepped down from the Board as Non-Executive Director. The Board thanks Steve and wishes him well as he leaves the Company to pursue other interests.

Euan is an international finance executive with over 35 years’ experience. Much of his career was spent at the Royal Bank of Scotland Group, until his retirement in 2011, during which time he held numerous roles, chiefly within the Leveraged Finance Division and latterly as Deputy CEO of the Non-Core Division.

In 2013, Euan joined Bank of Cyprus Group as Director in the group’s Restructuring and Recoveries Division, a role he held until 2015. He is currently a consultant for Bank of Cyprus and a non-executive director of the UK plc subsidiary.

Dan Wright, Executive Chairman of Accrol, said: “Euan is a finance professional of high standing, with clarity of thought, high standards and independence of mind. He appreciates the rigours of a turnaround situation and the demands of a restructuring from an operational perspective. I am sure the Board and business will benefit from his straight-forward objectivity and unremitting focus.”

“On behalf of the Board, I welcome Euan to the business and look forward to his contribution.”

About Accrol Group Holdings plc

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.

For more information :

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.